As the EU Falsified Medicines Directive (FMD) enforcement date draws closer, companies across the pharmaceutical industry are working hard to overcome implementation hurdles. One of the biggest challenges is fully understanding the scope of serialization projects and ensuring compliance in all the relevant markets.

In this Q&A with Contract Pharma, Pieter Vercruysse, Commercial Director at Tjoapack discusses how companies can best tackle these implementation challenges in the short time period that remains. Read the full article here: https://bit.ly/2BDyhzb.